Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox
NCT05476744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77
Last updated 2023-09-18
Summary
The present observational study has been designed to understand the dynamics of viral clearance amongst patients with confirmed monkeypox, by quantifying monkeypox viral load in different specimens trough time, to better inform decision-making about patient management and isolation guidelines. Also, an immune analysis will be performed in a subset of individuals to describe humoral and cellular responses to monkeypox.
Conditions
- Monkeypox
Sponsors & Collaborators
-
IrsiCaixa
collaborator OTHER -
CEEISCAT
collaborator UNKNOWN -
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-28
- Primary Completion
- 2022-09-22
- Completion
- 2023-03-30
Countries
- Spain
Study Locations
More Related Trials
-
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)
NCT07067723 ·Status: ENROLLING_BY_INVITATION
-
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)
NCT06984705 ·Status: ENROLLING_BY_INVITATION
-
Clinical and Biological Aspects of the MONKEYPOX Disease
NCT05627713 ·Status: RECRUITING ·Phase: NA
-
Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
NCT06136117 ·Status: COMPLETED
-
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
NCT05651581 ·Status: COMPLETED ·Phase: NA
-
A One Health Study of Monkeypox Human Infection
NCT05058898 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
NCT03631719 ·Status: COMPLETED
-
Clinical Prognostic Score to Predict Relapse in VL
NCT05602610 ·Status: RECRUITING
-
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
NCT07149753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.
NCT00471705 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
NCT01301924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
NCT01953744 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite
NCT00121849 ·Status: COMPLETED ·Phase: PHASE1
-
Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults
NCT01771848 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
NCT05493059 ·Status: UNKNOWN
-
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
NCT01032187 ·Status: COMPLETED ·Phase: PHASE4
-
New York City Observational Study of Mpox Immunity
NCT05654883 ·Status: ENROLLING_BY_INVITATION
-
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
NCT00600548 ·Status: COMPLETED ·Phase: PHASE2
-
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
NCT00469495 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19
NCT05679479 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
NCT03947437 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
NCT01377974 ·Status: COMPLETED ·Phase: PHASE2